Skip to contentS
Sanara MedTech Inc.
S
SMTISanara MedTech Inc. Q3 2017 · 10-Q
Revenue$1.55M$1.55M+9.9% vs Q3 2016 Net Income-$48.56K-$48.56KN/M vs Q3 2016 EPS Diluted$0.00$0.00— vs Q3 2016 Gross Profit$1,318,967+10.1% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sanara MedTech Inc. · CIK 714256 · Engraved from SEC EDGAR
Operating Cash Flowderived-$294,071N/M Free Cash Flowderived-$304,341N/M Margins · derivedGross margin85.1%+0.2 pt vs Q3 2016
Operating margin-1.9%−17.2 pt vs Q3 2016
Net margin-3.1%−16.0 pt vs Q3 2016
ended Sep 30, 2017 · filed Nov 16, 2017 · 47 d after period end